Lam Research Corporation
LAM RESEARCH CORP (Form: 3, Received: 05/30/2017 15:57:20)
FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Vahedi Vahid

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/22/2017 

3. Issuer Name and Ticker or Trading Symbol

LAM RESEARCH CORP [LRCX]

(Last)        (First)        (Middle)

C/O LAM RESEARCH CORPORATION, 4650 CUSHING PARKWAY

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Group Vice President /

(Street)

FREMONT, CA 94538       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   42999   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Market-based Performance Restricted Stock Unit     (2)   (2) Common Stock   6203.0   (2) $0.0   D    
Market-based Performance Restricted Stock Unit     (3)   (3) Common Stock   7957.0   (3) $0.0   D    
Market-based Performance Restricted Stock Unit     (4)   (4) Common Stock   5180.0   (4) $0.0   D    

Explanation of Responses:
(1)  Amount reported includes shares subject to unvested Restricted Stock Units.
(2)  These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/11/18. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/2/18.
(3)  These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/1/19. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/1/16 to 2/1/19.
(4)  These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/1/20. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/1/17 to 1/31/20.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Vahedi Vahid
C/O LAM RESEARCH CORPORATION
4650 CUSHING PARKWAY
FREMONT, CA 94538


Group Vice President

Signatures
Leign Cramer by Power of Attorney 5/30/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
POWER OF ATTORNEY



The undersigned hereby constitutes and appoints each of Peter Ornowski, Corporate Controller, Brenna
Hodgson, Sr. Finance Manager, Leign Cramer, Stock Administrator, and George Schisler, Vice President of
General Legal Affairs, signing singly, to be the undersigned's true and lawful attorney-in-fact to:



(1) prepare, execute in my name and on my behalf, and submit to the United States Securities and
Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other
documents necessary or appropriate to obtain codes and passwords enabling me to make
electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act
of 1934 ("Section 16(a)") or any rule or regulation of the SEC;



(2) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or
director of Lam Research Corporation (the "Company"), Forms 3, 4, and 5 in accordance with
Section 16(a) and the rules thereunder;



(3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or
desirable to complete and execute any such Form 3, 4, or 5, complete and execute any
amendment or amendments thereto, and timely file such form with the SEC and any stock
exchange or similar authority; and



(4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.



The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform
any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of
this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is
the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.



This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file
Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.



IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of
May 22, 2017.





/s/ Vahid Vahedi

 Signature



 Print Name: Vahid Vahedi